Major Milestone For Diurnal As FDA Approves Alkindi
Partner Eton Predicts $100m Sales For Adrenal Insufficiency Drug
The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.
